Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Ariel Liebert"'
Autor:
Ariel Liebert, Maria Kłopocka, Agata Michalak, Halina Cichoz-Lach, Renata Talar-Wojnarowska, Danuta Domz.ał-Magrowska, Łukasz Konecki, Aleksandra Filipiuk, Michał Krogulecki, Maria Kopertowska-Majchrzak, Kamila Stawczyk-Eder, Katarzyna Waszak, Piotr Eder, Edyta Zagórowicz, Izabela Smoła, Krzysztof Wojciechowski, Szymon Drygała
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 17 (2024)
Background: The Crohn’s Disease (CD) Activity Index (CDAI), Inflammatory Bowel Disease (IBD) Questionnaire (IBDQ), and IBD-Fatigue (IBD-F) scale are useful patient-reported outcome (PRO) tools for assessing the treatment benefits of vedolizumab (VD
Externí odkaz:
https://doaj.org/article/9b23c70480e14043ab860323a2f235c0
Autor:
Piotr Eder, Maria Kłopocka, Halina Cichoż-Lach, Renata Talar-Wojnarowska, Maria Kopertowska-Majchrzak, Agata Michalak, Rafał Filip, Katarzyna Waszak, Kamila Stawczyk-Eder, Maria Janiak, Krzysztof Skrobot, Ariel Liebert, Hubert Zatorski, Anna Solarska-Półchłopek, Michał Krogulecki, Anna Pękała, Elżbieta Poniewierka, Izabela Smoła, Aleksandra Kaczka, Krzysztof Wojciechowski, Szymon Drygała, Edyta Zagórowicz
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 16 (2023)
Background: Vedolizumab is a gut-selective anti-lymphocyte trafficking agent used to treat ulcerative colitis (UC) and Crohn’s disease. Objectives: We aimed to evaluate the effectiveness, safety, and durability of the therapeutic effect of vedolizu
Externí odkaz:
https://doaj.org/article/4af6e2e2447947e6be3468a5b721b17e
Publikováno v:
International Journal of Occupational Medicine and Environmental Health, Vol 35, Iss 2, Pp 157-167 (2021)
Objectives For homeless people, emergency departments (ED) are the place of medical care and satisfying physiological, safety and social needs. The treatment of the homeless in EDs is a common issue in many countries. The aim of study was to analyze
Externí odkaz:
https://doaj.org/article/e677073503914651ae2760fcd7fa4b3e
Autor:
Halina Cichoż-Lach, Agata Michalak, Maria Kopertowska-Majchrzak, Piotr Eder, Kamila Stawczyk-Eder, Katarzyna Waszak, Renata Talar-Wojnarowska, Hubert Zatorski, Anna Solarska-Półchłopek, Jarosław Chmielnicki, Rafał Filip, Anna Pękala, Maria Janiak, Krzysztof Skrobot, Ewa Kasińska, Michał Krogulecki, Piotr Królikowski, Maria Kłopocka, Ariel Liebert, Elżbieta Poniewierka, Izabela Smoła, Anita Gąsiorowska, Aleksandra Kaczka, Joanna Wypych, Krzysztof Wojciechowski, Szymon Drygała, Edyta Zagórowicz
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 14 (2021)
Background: Vedolizumab, a humanized antibody targeting the α 4 β 7 integrin, was proven to be effective in the treatment of moderate-to-severe ulcerative colitis (UC) in randomized clinical trials. The aim of the POLONEZ study is to determine the
Externí odkaz:
https://doaj.org/article/7e2ecacc62f2490e8a93843687e72371
Autor:
Małgorzata Nartowicz, Aleksandra Jaworska-Czerwińska, Małgorzata Chudzińska, Beata Pilarska, Ariel Liebert, Malwina Barańska, Kamila Tymosiak, Elżbieta Bernaciak, Walery Zukow
Publikováno v:
Journal of Education, Health and Sport, Vol 8, Iss 12, Pp 785-792 (2018)
Protocol ERAS - "Enhanced Recovery after Surgery" - is a modern multidisciplinary formula of perioperative care to improve treatment outcomes. Over the past few years, many attempts have been made to implement recommendations for the management of pa
Externí odkaz:
https://doaj.org/article/94af1f8cbf8a409abfa34ea6c1ac18e0
Autor:
Marta Starczak, Ewelina Zarakowska, Martyna Modrzejewska, Tomasz Dziaman, Anna Szpila, Kinga Linowiecka, Jolanta Guz, Justyna Szpotan, Maciej Gawronski, Anna Labejszo, Ariel Liebert, Zbigniew Banaszkiewicz, Maria Klopocka, Marek Foksinski, Daniel Gackowski, Ryszard Olinski
Publikováno v:
Journal of Translational Medicine, Vol 16, Iss 1, Pp 1-11 (2018)
Abstract Background A characteristic feature of malignant cells, such as colorectal cancer cells, is a profound decrease in the level of 5-hydroxymethylcytosine, a product of 5-methylcytosine oxidation by TET enzymes. Recent studies showed that ascor
Externí odkaz:
https://doaj.org/article/507636277e8b48f1a1b4f317954fc4dc
Autor:
Tomasz Dziaman, Daniel Gackowski, Jolanta Guz, Kinga Linowiecka, Magdalena Bodnar, Marta Starczak, Ewelina Zarakowska, Martyna Modrzejewska, Anna Szpila, Justyna Szpotan, Maciej Gawronski, Anna Labejszo, Ariel Liebert, Zbigniew Banaszkiewicz, Maria Klopocka, Marek Foksinski, Andrzej Marszalek, Ryszard Olinski
Publikováno v:
Clinical Epigenetics, Vol 10, Iss 1, Pp 1-11 (2018)
Abstract Background Active demethylation of 5-methyl-2′-deoxycytidine (5-mdC) in DNA occurs by oxidation to 5-(hydroxymethyl)-2′-deoxycytidine (5-hmdC) and further oxidation to 5-formyl-2′-deoxycytidine (5-fdC) and 5-carboxy-2′-deoxycytidine
Externí odkaz:
https://doaj.org/article/fd38b53e8df744ab9c03def9dba142b4
Autor:
Maciej Bieliński, Natalia Lesiewska, Joanna Bielińska, Ariel Liebert, Artur Mieczkowski, Paulina Sopońska-Brzoszczyk, Bartosz Brzoszczyk, Maria Kłopocka, Alina Borkowska
Publikováno v:
PLoS ONE, Vol 13, Iss 11, p e0205606 (2018)
Psychiatric disorders are significantly common complications among patients suffering from inflammatory bowel diseases (IBD). Affective temperament is a concept of core personality traits, which can decribe the vulnerability to mood disorders, theref
Externí odkaz:
https://doaj.org/article/10821a90cc8340ada2732659f5e4634f
Publikováno v:
Case Reports in Medicine, Vol 2014 (2014)
Variety of symptoms and atypical clinical course of Crohn’s disease (CD) often create the need for additional diagnostic procedures. In the described case of woman with CD, there was a suspicion of coexistence of ovarian cancer. This issue is parti
Externí odkaz:
https://doaj.org/article/21e9d4847d384df4a1d65d8b4946bba5
Autor:
Edyta Zagórowicz, Halina Cichoż-Lach, Maria Kopertowska-Majchrzak, Piotr Eder, Kamila Stawczyk-Eder, Renata Talar-Wojnarowska, Hubert Zatorski, Anna Solarska-Półchłopek, Rafał Filip, Maria Janiak, Krzysztof Skrobot, Maria Kłopocka, Ariel Liebert, Aleksandra Kaczka, Krzysztof Wojciechowski, Szymon Drygała, Agata Michalak
Supplementary Table 1. Changes in Mayo subscales from week 0 to week 14 of induction therapy with vedolizumab in biologic-naïve, biologic-exposed, and biofailure patients with ulcerative colitis. Supplementary Table 2. Adverse events in patients wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::240a8db33ead5f1388fb40e0e9051752
